kynurenine has been researched along with Carcinoma, Epidermoid in 8 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Esophageal squamous cell carcinoma (ESCC) is one of the most frequent malignancies worldwide." | 5.46 | Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma. ( Cheng, J; Gao, X; Hou, X; Jin, H; Lv, J; Zheng, G, 2017) |
| " We investigated the associations for circulating levels of tryptophan, kynurenine, kynurenine:tryptophan ratio (KTR), quinolinic acid (QA) and neopterin as markers of immune regulation and inflammation with lung cancer risk in 5,364 smoking-matched case-control pairs from 20 prospective cohorts included in the international Lung Cancer Cohort Consortium." | 3.96 | Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3). ( Albanes, D; Alcala, K; Arslan, AA; Blot, WJ; Brennan, P; Buring, JE; Cai, Q; Caporaso, NE; Fanidi, A; Freedman, ND; Gao, YT; Gaziano, JM; Giles, GG; Grankvist, K; Haiman, CA; Han, J; Hodge, AM; Huang, JY; Hveem, K; Johansson, M; Koh, WP; Lan, Q; Langhammer, A; Larose, TL; Le Marchand, L; Lee, IM; Li, HL; Luu, HN; Manjer, J; Midttun, Ø; Pettinger, M; Prentice, RL; Purdue, MP; Relton, C; Sesso, HD; Severi, G; Shu, XO; Stampfer, MJ; Stevens, VL; Thomson, CA; Ueland, PM; Ulvi, A; Visvanathan, K; Wang, R; Weinstein, SJ; Wilkens, LR; Wu, J; Xiang, YB; Yuan, JM; Zeleniuch-Jacquotte, A; Zhang, X; Zheng, W; Ziegler, RG, 2020) |
| " Our results suggest that RT alters IDO-mediated immune status in NSCLC patients and that changes in this serum biomarker may be useful to predict outcomes and perhaps personalize RT dosage to improve survival." | 1.48 | IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients. ( Huang, L; Jin, JY; Jolly, S; Kong, FS; Li, L; Mellor, AL; Pi, W; Wang, W; Wu, H; Yan, L; Zang, Y, 2018) |
| "Treatment of lung cancer is evolving from the use of cytotoxic drugs to drugs that interrupt pathways specific to a malignancy." | 1.48 | Diagnosis of lung tumor types based on metabolomic profiles in lymph node aspirates. ( Bartter, T; Boysen, G; Helms, S; Jeffus, S; Penney, RB; Sappington, D; Siegel, E, 2018) |
| "Esophageal squamous cell carcinoma (ESCC) is one of the most frequent malignancies worldwide." | 1.46 | Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma. ( Cheng, J; Gao, X; Hou, X; Jin, H; Lv, J; Zheng, G, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riess, C | 1 |
| Schneider, B | 1 |
| Kehnscherper, H | 1 |
| Gesche, J | 1 |
| Irmscher, N | 1 |
| Shokraie, F | 1 |
| Classen, CF | 1 |
| Wirthgen, E | 1 |
| Domanska, G | 1 |
| Zimpfer, A | 1 |
| Strüder, D | 1 |
| Junghanss, C | 1 |
| Maletzki, C | 1 |
| Zhou, QH | 1 |
| Han, H | 1 |
| Lu, JB | 1 |
| Liu, TY | 1 |
| Huang, KB | 1 |
| Deng, CZ | 1 |
| Li, ZS | 1 |
| Chen, JP | 1 |
| Yao, K | 1 |
| Qin, ZK | 1 |
| Liu, ZW | 1 |
| Li, YH | 1 |
| Guo, SJ | 1 |
| Ye, YL | 1 |
| Zhou, FJ | 1 |
| Liu, RY | 1 |
| Mandarano, M | 1 |
| Orecchini, E | 1 |
| Bellezza, G | 1 |
| Vannucci, J | 1 |
| Ludovini, V | 1 |
| Baglivo, S | 1 |
| Tofanetti, FR | 1 |
| Chiari, R | 1 |
| Loreti, E | 1 |
| Puma, F | 1 |
| Sidoni, A | 1 |
| Belladonna, ML | 1 |
| Cheng, J | 1 |
| Jin, H | 1 |
| Hou, X | 1 |
| Lv, J | 1 |
| Gao, X | 1 |
| Zheng, G | 1 |
| Wang, W | 1 |
| Huang, L | 1 |
| Jin, JY | 1 |
| Jolly, S | 1 |
| Zang, Y | 1 |
| Wu, H | 1 |
| Yan, L | 1 |
| Pi, W | 1 |
| Li, L | 1 |
| Mellor, AL | 1 |
| Kong, FS | 1 |
| Sappington, D | 1 |
| Helms, S | 1 |
| Siegel, E | 1 |
| Penney, RB | 1 |
| Jeffus, S | 1 |
| Bartter, T | 2 |
| Boysen, G | 1 |
| Huang, JY | 1 |
| Larose, TL | 1 |
| Luu, HN | 1 |
| Wang, R | 1 |
| Fanidi, A | 1 |
| Alcala, K | 1 |
| Stevens, VL | 1 |
| Weinstein, SJ | 1 |
| Albanes, D | 1 |
| Caporaso, NE | 1 |
| Purdue, MP | 1 |
| Ziegler, RG | 1 |
| Freedman, ND | 1 |
| Lan, Q | 1 |
| Prentice, RL | 1 |
| Pettinger, M | 1 |
| Thomson, CA | 1 |
| Cai, Q | 1 |
| Wu, J | 1 |
| Blot, WJ | 1 |
| Shu, XO | 1 |
| Zheng, W | 1 |
| Arslan, AA | 1 |
| Zeleniuch-Jacquotte, A | 1 |
| Le Marchand, L | 1 |
| Wilkens, LR | 1 |
| Haiman, CA | 1 |
| Zhang, X | 1 |
| Stampfer, MJ | 1 |
| Han, J | 1 |
| Giles, GG | 1 |
| Hodge, AM | 1 |
| Severi, G | 1 |
| Johansson, M | 2 |
| Grankvist, K | 1 |
| Langhammer, A | 1 |
| Hveem, K | 1 |
| Xiang, YB | 1 |
| Li, HL | 1 |
| Gao, YT | 1 |
| Visvanathan, K | 1 |
| Ueland, PM | 1 |
| Midttun, Ø | 1 |
| Ulvi, A | 1 |
| Buring, JE | 1 |
| Lee, IM | 1 |
| Sesso, HD | 1 |
| Gaziano, JM | 1 |
| Manjer, J | 1 |
| Relton, C | 1 |
| Koh, WP | 1 |
| Brennan, P | 1 |
| Yuan, JM | 1 |
| Hascitha, J | 1 |
| Priya, R | 1 |
| Jayavelu, S | 1 |
| Dhandapani, H | 1 |
| Selvaluxmy, G | 1 |
| Sunder Singh, S | 1 |
| Rajkumar, T | 1 |
8 other studies available for kynurenine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Squamous Cell; Cell Line | 2020 |
Up-regulation of indoleamine 2,3-dioxygenase 1 (IDO1) expression and catalytic activity is associated with immunosuppression and poor prognosis in penile squamous cell carcinoma patients.
Topics: Adult; Aged; Aged, 80 and over; B7-H1 Antigen; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Lin | 2020 |
Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer.
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; Biomarkers, Tumor; Carcinoma, | 2021 |
Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
Topics: 5-Hydroxytryptophan; Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Diseas | 2017 |
IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; C | 2018 |
Diagnosis of lung tumor types based on metabolomic profiles in lymph node aspirates.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biopsy, Needle; Carcinoma, Squamous Cell; Female; Glutathio | 2018 |
Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3).
Topics: Adenocarcinoma of Lung; Adult; Aged; Biomarkers, Tumor; Carcinoma, Large Cell; Carcinoma, Squamous C | 2020 |
Analysis of Kynurenine/Tryptophan ratio and expression of IDO1 and 2 mRNA in tumour tissue of cervical cancer patients.
Topics: Adenocarcinoma; Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Chromatography, H | 2016 |